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BACKGROUND: Prioritising control measures for occupationally related cancers should be evidence based. We estimated the
current burden of cancer in Britain attributable to past occupational exposures for International Agency for Research on Cancer
(IARC) group 1 (established) and 2A (probable) carcinogens.
METHODS:We calculated attributable fractions and numbers for cancer mortality and incidence using risk estimates from the literature
and national data sources to estimate proportions exposed.
RESULTS: 5.3% (8019) cancer deaths were attributable to occupation in 2005 (men, 8.2% (6362); women, 2.3% (1657)). Attributable
incidence estimates are 13679 (4.0%) cancer registrations (men, 10063 (5.7%); women, 3616 (2.2%)). Occupational attributable
fractions are over 2% for mesothelioma, sinonasal, lung, nasopharynx, breast, non-melanoma skin cancer, bladder, oesophagus, soft
tissue sarcoma, larynx and stomach cancers. Asbestos, shift work, mineral oils, solar radiation, silica, diesel engine exhaust, coal tars
and pitches, occupation as a painter or welder, dioxins, environmental tobacco smoke, radon, tetrachloroethylene, arsenic and strong
inorganic mists each contribute 100 or more registrations. Industries and occupations with high cancer registrations include
construction, metal working, personal and household services, mining, land transport, printing/publishing, retail/hotels/restaurants,
public administration/defence, farming and several manufacturing sectors. 56% of cancer registrations in men are attributable to work
in the construction industry (mainly mesotheliomas, lung, stomach, bladder and non-melanoma skin cancers) and 54% of cancer
registrations in women are attributable to shift work (breast cancer).
CONCLUSION:This project is the first to quantify in detail the burden of cancer and mortality due to occupation specifically for Britain.
It highlights the impact of occupational exposures, together with the occupational circumstances and industrial areas where
exposures to carcinogenic agents occurred in the past, on population cancer morbidity and mortality; this can be compared with the
impact of other causes of cancer. Risk reduction strategies should focus on those workplaces where such exposures are still occurring.
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& 2010 Cancer Research UK
Keywords: occupation; cancer burden; attributable fraction; industry sector; carcinogen
                                                                                                                                   
Reduction of occupationally related cancers requires sound
evidence on which to base priorities. Recognition and classifica-
tion of a substance as a carcinogen is made through scrutiny and
assessment of a wide range of evidence including in vivo, in vitro
and human studies. For substances that are already established as
human carcinogens, for example using the International Agency
for Research on Cancer (IARC) classification, estimation of
attributable burden provides useful indicators of the contribution
of different risk factors and has become widely used in public
health research (Lopez et al, 2006). Risk reduction can thus
incorporate consideration of risk level with the size of potentially
exposed populations. A comprehensive review of the proportions
of cancer from different causes in the United States estimated, the
contribution of occupational factors as 4% with an uncertainty range
of 2–8% (Doll and Peto, 1981). These estimates have been used to
formulate occupational health policies in many countries, including
Britain. More recently Doll and Peto (2005) have also produced an
estimate for Britain of 2% with a range of 1–5%; they suggested that
less than 1% is avoidable by practicable ways (Doll and Peto, 2005).
Budget rationing based on underestimates of the cancer burden
attributed to occupation will almost certainly overlook important
issues. Conversely, overestimation of the cancer burden may result
in tighter regulation, which may impede industry. Therefore, it is
important to develop rigorous methodology to estimate cancer
burden, which is adaptable to a given country.
The attributable fraction (AF) is widely used, for example, in the
estimation of global burden of disease (Driscoll et al, 2005);
quantification and ranking of the burden by diseases and causes
of disease facilitate decision making for risk reduction measures.
Our paper presents an evaluation of the burden of cancer in Britain
for all carcinogenic agents and occupations classified by IARC as a
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occupational exposures, had either ‘strong’ or ‘suggestive’ evidence
of carcinogenicity in humans for the specific cancer site, as defined
by Siemiatycki et al (2004) and subsequent IARC publications
(Rousseau et al, 2005; Straif et al, 2005, 2007). We identify
carcinogens, occupations and industry sectors that make an
important contribution to the total burden.
MATERIALS AND METHODS
Preliminary results for six cancer sites, showing the developing
methodology have been previously published (Rushton et al,
2008). For this paper, estimations were carried out using 2005 data
for mortality and 2004 for cancer incidence. Mortality data were
obtained from the Office for National Statistics (ONS), and the
General Register Office for Scotland. Cancer incidence data were
obtained from ONS, Cancer Statistics, Registrations, Series MB1
for England, the Scottish Cancer Registry, and the Welsh Cancer
Intelligence and Surveillance Unit.
We estimated the AF, that is, the proportion of cases that would
not have occurred in the absence of an occupational exposure; this
was then used to estimate the attributable numbers (ANs). There
are several methods for estimating the AF but all depend on
knowledge of the disease risk due to the exposure of interest and
the proportion of the target population exposed (Steenland and
Armstrong, 2006).
Risk estimates were obtained from key studies, meta-analyses or
pooled studies, taking into account quality (including relevance
to Britain, sample size, extent of control for confounders, adequacy
of exposure assessment and clarity of case definition). Where
possible we selected risk estimates adjusted for important
confounders or non-occupational risk factors, for example,
smoking for lung cancer, smoking and alcohol use for laryngeal
cancer. Where only a narrative review was available giving a range
of risk estimates, we calculated a combined estimate of the relative
risks (RRs) based on a random-effects (for heterogeneous RRs) or
fixed-effects (for homogeneous RRs) model. Formal systematic
reviews and meta-analyses were carried out to estimate risk
estimates for laryngeal and stomach cancers related to asbestos
exposure.
Dose–response risk estimates were generally not available in the
epidemiological literature nor were proportions of those exposed
at different levels of exposure over time available for the working
population in Britain. However, where possible risk estimates were
obtained for an overall ‘lower’ level and an overall ‘higher’ level of
exposure to the agents of concern. The risk estimates for
occupational exposure to ionising radiation were derived using
generalised linear dose–response models of excess RR per unit
of cumulative radiation dose from the United Nations
Scientific Committee on the Effects of Atomic Radiation
(UNSCEAR, 2006). Cumulative lifetime dose was estimated using
data from the Central Index of Dose Information (CIDI) (HSE,
1998). For aircrew, who are not covered by CIDI, the mean total
lifetime radiation dose per pilot was obtained from a large cohort
study of European airline pilots (Langner et al, 2004) and
combined with numbers employed obtained from the British
Airways Stewards and Stewardesses Union (BASSA, personal
communication, 2008).
A substantial proportion of the excess is likely to occur in the
large number of workers with low exposures for whom our
estimates of average risks are inevitably unreliable. Where no risk
estimate could be identified for very low or background levels of
exposure, we estimated an RR for the ‘lower exposed’ group by
(1) taking the harmonic mean of all the available ratios of ‘higher’
to ‘lower’ RR estimates for cancer-exposure pairs for which data
were available and (2) applying this average ratio to the ‘higher’
level estimates to obtain ‘lower’ level RR estimates; if this was less
than one, it was set to one. (In the developmental phase of the
study, an RR of one was arbitrarily assigned, giving zero AF and so
possibly underestimating the burden; a large number of people
exposed at low levels associated with a low risk of disease may
contribute more to the burden than a small number exposed at
high levels associated with a high risk.)
We defined the period during which the relevant exposure for
the cancer in the target year 2005 as the risk exposure period
(REP). For solid tumours, a latency of 10–50 years was assumed
giving an REP of 1956–1995; for haematopoietic neoplasms, 0–20
year’s latency was assumed giving an REP of 1986–2005. The
proportion of the population ever exposed to each carcinogenic
agent or occupation in the REP was obtained from the ratio of the
numbers ever exposed to the carcinogens of interest in each
relevant industry or occupation within Britain over the total
number of people ever employed (Equation (4) in the Statistical
Appendix).
If the study from which the risk estimates were obtained
was population based, an estimate of the proportion of the
population exposed was derived directly from the study data,
although such studies were rarely available for Britain. If the risk
estimate was obtained from an industry-based study, national data
sources such as the CARcinogen EXposure (CAREX) database
(Pannett et al, 1998), the UK Labour Force Survey (LFS) (LFS,
2009) and the Census of Employment (ONS, 2009) were
used. CAREX was used for estimating the numbers of the British
population ever exposed to a carcinogen by industry sector. As
highlighted above, data are not available on the levels of exposure
in all industry sectors for all the carcinogens considered, nor the
numbers exposed at these levels. Industry sectors were therefore
allocated to ‘higher’ or ‘lower’ exposure categories assuming
distributions of exposure and risk that corresponded broadly
to those of the studies from which the risk estimates were
selected. The initial allocations were based on the judgement of
an experienced human exposure scientist; each assessment
was then independently peer reviewed and if necessary, a
consensus assessment agreed. Data from CAREX are not
differentiated by sex; 1991 Census data by industry and occupation
were used to estimate the relative proportions of men and women
exposed. The LFS and Census of Employment data were used to
estimate numbers ever employed in specific occupations, for
example, welder, painter and so on, and for specific industries for
carcinogens not included in CAREX.
CAREX data for Britain relate only to the period 1990–1993. For
the LFS and CoE, an available year was chosen to represent
numbers employed about 35 years before the target year of 2005,
as this was thought to represent a ‘peak’ latency for the solid
tumours, and is also close to the mid-point of the REP for
estimating numbers ever exposed across the period (for which a
linear change in employment levels was implicitly assumed).
Where the Census of Employment was used, the data are for 1971.
Where the LFS was used, the first year available and therefore used
was 1979 for solid tumours, and 1991 for short latency cancers.
When CAREX data were used, adjustment factors were applied to
take account of the change in numbers employed in the primary
and manufacturing industry and service sectors in Britain over the
REP. Adjustment for employment turnover over the period for
grouped main industry sectors was also carried out (see Equation
(3) in the Statistical Appendix). Ideally this requires full national
starter and leaver data across the REP for all industry sectors.
In the absence of this quality of data, estimating turnover directly
using new starters in years within the REPs gives the best
approximation for the purpose of estimating those ever exposed.
This method estimates starters in the past year as a proportion
of the average number employed (Gregg and Wadsworth, 2002).
As exposure in occupational epidemiological studies is usually
defined as for at least 1 year, we have adapted this to exclude short-
term labour turnover by taking new starters in the past year who
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of all those expected to be employed for at least 1 year. This is
estimated as the number recorded as employed for between 1 and 2
years divided by the total employed for at least 1 year using
LFS data averaged over the REP.
Statistical analysis
To estimate the AFs for each cancer and occupational carcinogen,
we used Levin’s method if risk estimates came from an industry-
based study, a review or meta-analysis, together with estimates
of the proportion of the population exposed from independent
national sources of data (Levin, 1953). Miettinen’s method was
used if risk estimates and proportions exposed came from a
population-based study (Miettinen, 1974) (Equations (1) and (2),
respectively, in the Statistical Appendix). For each AF, a random
error confidence interval was calculated using Monte Carlo
simulations (Steenland and Armstrong, 2006). The AFs were
applied to total numbers of cancer-specific deaths (2005) and
cancer registrations (2004) for ages that could have been exposed
during the REP to give ANs. Where risk estimates were only
available from mortality studies, AFs derived from these were used
for estimation of attributable registrations and vice versa. Similarly
if separate AFs for women could not be estimated, those for men or
for men and women combined were used.
The AF for mesothelioma was derived directly from several UK
mesothelioma studies that suggest 96–98% of male mesothelioma
cases are due to occupational or paraoccupational (e.g., exposure
from living near an asbestos factory or handling clothes
contaminated due to occupational exposure) exposure (Howel
et al, 1997; Yates et al, 1997; Rake et al, 2009). Combining the
results from Rake et al (2009) with those from two studies in which
results were reported separately for females (Spirtas et al, 1994;
Goldberg et al, 2006) gave estimates of 75–90% for females. The
ratio of asbestos-related lung cancer to mesothelioma deaths has
been suggested to be between two-thirds and one (Darnton et al,
2006). Rather than our standard method for the estimation of
numbers of lung cancers attributable to asbestos, we therefore used
a ratio of 1:1 mesothelioma to lung cancer deaths; this takes into
account the impact that past levels of asbestos exposure are having
on current incidence by the direct link to mesothelioma deaths
that are still climbing whereas lung cancer in general is declining
due to the reduction in smoking. This assumes, however, that
lung cancer has a similar pattern of latency as mesothelioma.
For lung cancer associated with radon exposure from natural
sources, estimates of rates of lung cancer due to exposure to radon
in domestic buildings (NRPB, 2000) were applied to estimates
of the time employees spend in workplaces where radon exposure
occurs.
AFs for all the relevant carcinogenic agents and occupational
circumstances were combined into a single estimate of AF for each
separate cancer. To take account of potential multiple exposures,
we used strategies including partitioning exposed numbers
between overlapping exposures or estimating only for the
‘dominant’ carcinogen with the highest risk. The IARC Monograph
process has been taking place over many years and has resulted in
overlap between substances evaluated. For lung cancer, for
example, 32 occupations or carcinogenic agents are evaluated.
We estimated AFs for 21 of these; for example, substances such as
coal tars and pitches and processes such as coal gasification and
coke production were included within our evaluation of polycyclic
aromatic hydrocarbons (PAHs). Where exposure to multiple
carcinogens remained, it was assumed that the exposures were
independent of one another and that their joint carcinogenic
effects were multiplicative. The AFs were then combined to give an
overall AF for that cancer using a product sum (Equation (5) in the
Statistical Appendix). An overall AF for all cancers was estimated
by summing the ANs for each and dividing by the total number of
cancers in Britain.
RESULTS
The overall burden by cancer site (AFs, ANs and 95% confidence
intervals) is given in Table 1. In all, 8.2% (n¼6362) of cancer
deaths in 2005 in men and 2.3% (n¼1657) in women in Britain
have been estimated to be due to occupation giving an overall AF
of 5.3% (n¼8019). The combined AFs for registrations are 5.7%
(n¼10063) for men in 2004 and 2.2% (n¼3616) for women
giving an overall AF based on registrations of 4.0% (n¼13679).
These are lower than for deaths because of the large numbers
of non-melanoma skin cancer (NMSC). The results for four of the
cancers, bladder, leukaemia, NMSC and sinonasal, are lower
than previously estimated (Rushton et al, 2008) mainly due to
reallocation of some of the industry sectors from ‘higher’ to ‘lower’
exposure categories after more in-depth review of the exposures in
Britain. If only agents and occupations classified by IARC as group
1 and having strong evidence of carcinogenicity in humans are
considered, the overall burden reduces to 4.0% (5123 total deaths,
8277 total registrations) (Supplementary Table A1). Only nine
cancer sites are involved (bladder, larynx, leukaemia, liver, lung,
mesothelioma, NMSC, sinonasal and thyroid). The dominance of
asbestos exposure and mesothelioma, asbestos and the many other
group 1 carcinogens relevant to lung cancer, and solar radiation
(SR) and NMSC means that the reduction in the AFs and ANs
for men (6.6%, 5123 deaths, 8277 registrations) is far less than for
women (1.2%, 862 deaths, 1313 registrations) for whom shift work
is most dominant.
The AFs by cancer site range from less than 0.01–95% overall,
the most important cancer sites for occupational attribution being,
for men, mesothelioma (97%), sinonasal (46%), lung (21.1%),
bladder (7.1%) and NMSC (7.1%), and for women, mesothelioma
(83%), sinonasal (20.1%), lung (5.3%), breast (4.6%) and
nasopharynx (2.5%). Occupation also contributes 2% or more
overall to cancers of the larynx, oesophagus, soft tissue sarcoma
(STS) and stomach, with in addition for men melanoma of the eye
(due to welding) and non-Hodgkin’s lymphoma (NHL).
Table 2 gives the number of registrations in 2004 by cancer
site for each cancer attributable to each of the 41 agents and
occupations for which separate estimation was carried out,
considered in rank order. Of these, 15 contributed over 100 total
cancer registrations, the largest being asbestos exposure
(mesothelioma (1937), lung (2223), larynx (8) and stomach
cancers (47)), followed in order by shift work, including flight
personnel (breast (1969), mineral oils (bladder (296), lung (470),
NMSC (902), sinonasal (63)), SR (NMSC (1541)), silica (lung
(907)), diesel engine exhaust (DEE) (lung (695), bladder (106)),
PAHs from coal tar and pitches (NMSC (545)), occupation as a
painter (bladder (71), lung (282), stomach (5)), dioxins (lung
(215), NHL (74), STS (27)), environmental tobacco smoke (ETS) at
work in non-smokers (lung (284)), radon exposure from natural
exposure in workplaces (lung (209)), occupation as a welder (lung
(175), and melanoma of the eye due to UV radiation (6)),
tetrachloroethylene (cervix (18), NHL (17), oesophagus (130)),
arsenic (lung (129)) and strong inorganic acid mists (larynx (46),
lung (76)). The results in this table highlight the fact that many
carcinogenic exposures in the workplace can affect multiple
cancer sites.
Table 3 gives numbers of registrations within industry sectors
or occupations for which there were at least 50 total attributable
registrations. The exposures concerned in each industry sector are
listed, with those contributing most (at least a total of 10 cancers)
being shown in bold. Painters and welders are assumed to be
exposed to many different carcinogens. Also given are the relevant
cancer sites for each industry sector with the most important
Occupational cancer burden in GB
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60 industry sectors, 21 have 100 or more total attributable
registrations. The majority of industry sectors involve exposure
to several carcinogens (many over 10) with construction and many
of the manufacturing sectors involving potential exposure to
between 15 and 20. In addition, the potential occurrence of several
exposures in what might be thought of as less traditionally exposed
sectors, such as the retail and service industries, is highlighted.
There are several key exposures that give rise to substantial
numbers of registrations across multiple cancer sites and multiple
industry sectors. Of note is the contribution of exposure to
(1) asbestos, DEE, silica and SR in the construction industry;
(2) asbestos, DEE, ETS (non-smokers), soots and tetrachloro-
ethylene in personal and household services (this sector includes
repair trades, laundries and dry cleaning, domestic services,
hairdressing and beauty); (3) asbestos and DEE in land transport
(railway, road and pipeline); (4) asbestos, DEE, silica and SR in
mining; (5) ETS (non-smokers) and SR in public administration
and defence; (6) asbestos, ETS (non-smokers) and radon in the
wholesale and retail trade, restaurants and hotels; and (7) dioxins,
non-arsenical pesticides and SR in farming.
DISCUSSION
Our study has quantified for the first time the impact of
occupation on the burden of cancer in Britain for all 24 cancer
sites and the carcinogens that IARC have classified as having
sufficient (group 1) or limited (group 2A) evidence in humans.
Unlike other estimates of cancer burden, we have also evaluated
the impact within different industry sectors, so facilitating
prioritisation and implementation of preventive action. Our results
are greater than other estimates for some cancer sites, partly due
to differences in the numbers of cancers and carcinogens
considered. For example, the global estimate of occupational
cancer (Driscoll et al, 2005) included only lung cancer, leukaemia
and mesothelioma; their estimate for lung cancer included
only eight carcinogens, arsenic, asbestos, beryllium, cadmium,
chromium, DEE, nickel and silica. The 13 additional agents in our
study contributed 34% of the total attributable registrations from
lung cancer. The relative importance of different cancer sites also
changes as more cancer sites are included, with leukaemia
(included in the global estimate) being less important in our
study than other sites, including other haematopoietic malignan-
cies such as NHL.
Our methodology was developed with advice, discussion and
peer review from international experts, including IARC, through-
out the project and at two international workshops. It takes
account of issues such as latency and the period in which relevant
exposure would occur, changes in workforce turnover and
employment trends and the potential for concurrent exposure to
several carcinogens and at different levels. These methods have the
potential to be adapted for use in other countries and extended
to include social and economic impact evaluation. For example,
both the methods and results from the study are currently being
used to inform an EU project to assess the socioeconomic impact
of, and make recommendations for, new occupational exposure
limits for the European Union for 25 recognised carcinogens. It is
also being used to underpin the on-going update of the World
Health Organisation Global Burden of Disease.
However, assumptions made in our methodology and uncer-
tainties and inaccuracies in our data may have introduced biases
into our estimates, the impact of which is not fully captured in the
confidence intervals presented. Potential sources of bias include
inappropriate choice of risk estimates, imprecision in the risk
estimates and estimates of proportions exposed, inaccurate
REP and latency assumptions and a lack of separate risk
estimates in some cases for women and/or cancer incidence.
Future work will explore the sensitivity of the estimates to such
sources of uncertainty and bias. Our estimates do not include
evaluation of the results from an on-going review and update
of all group 1 carcinogens, which IARC is carrying out separately
for cancer sites. This classification can vary for the
same substance; thus, asbestos is classified as group 1 for
mesothelioma and cancers of the larynx, lung and ovary and as
group 2A for colorectal, pharyngeal and stomach cancers (Straif
et al, 2009).
Our estimate of the fraction of current cancer deaths in Britain
due to past occupational exposures is at the upper limit of the
range of 1–5% suggested by Doll and Peto (2005). The earlier and
much higher estimate for the United States in the unpublished
but widely cited report by Bridbord et al (1978) was criticised by
Doll and Peto (1981) for disregarding both dose and duration of
exposure and assuming that all workers (including some
unexposed) were at equally high risk. The ideal requirement
would be quantitative exposure estimates in Britain for each of the
relevant cancers and carcinogens; unfortunately, these are rarely
available. However, we have been careful to use estimates of RR
from studies that were conducted in populations where exposure
levels are representative of the level of risk to which British
workers are likely to have been exposed. The allocation of
industries included in CAREX to ‘higher’ or ‘lower’ exposure level
categories was also based on the levels of exposure described in the
study from which the risk estimates were drawn. Where CAREX
data were not available, estimates of numbers employed were
obtained from the LFS or Census of Employment; job or industry
categories were chosen that conformed as nearly as possible those
in the studies from which the RRs were drawn. In addition, the
risk estimates from the literature usually related to an estimate of
cumulative exposure. In assigning ‘higher’ and ‘lower’ categories
to the CAREX industry groups, implicit assumptions were made
regarding the similarity of durations and intensities of exposure
between the source and target (national) populations. National
data are not generally available on the proportions of those
exposed at different levels of exposure, nor does the United
Kingdom have a national job exposure matrix such as those
developed in Finland and the United States (Antilla et al, 1992;
Greife et al, 1995).
Due to the long latent interval of many carcinogens, our
estimates of current burden are based on past exposures, many of
which would have been considerably higher than today; there is
evidence of continuing downward trends in the United Kingdom
in many exposures (Cherrie et al, 2007). A comprehensive analysis
of published exposure data, particularly in Western Europe and
North America, has shown similar patterns of decreasing exposure
patterns across a wide range of industries and substances
(Symanski et al, 1998a,b). It should be noted that for many of
the carcinogens in our study a major contribution to the burden
was made by a large number of workers exposed at low levels and
low risk for which our quantitative risk estimates are inevitably
uncertain. Our study has highlighted the fact that many workers
may potentially be exposed to several carcinogens and that
these may affect multiple cancer sites. Key carcinogens and
industry sectors have been identified posing varying challenges
for risk reduction strategies; these include asbestos, DEE, ETS
(non-smokers), radon, silica, SR and shift work.
Substantial exposure to asbestos in Britain until the 1970s has
contributed to a continuing rise in asbestos-related deaths from
lung cancer and mesothelioma (Hodgson et al, 2005); asbestos
contributes 30% of the occupationally related cancer registrations
and nearly half of the deaths in our study. This highlights exposure
in the construction industry along with other dusts such as those
containing silica. A recent case–control study of UK mesothelioma
patients found high risks associated with asbestos exposure in the
construction industry, including work as a plumber, electrician,
painter or decorator Rake et al (2009). It was suggested that a
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those who installed asbestos installation board as fireproofing;
the large amount of asbestos that remains in many older buildings
may still be a potential hazard to construction workers involved
in renovation, maintenance or asbestos removal. Difficulties of
managing asbestos exposures arising during industrial mainte-
nance and repair and the problems of health protection of workers
worldwide have been reported (Wagner, 2007). Exposure to dusts
containing silica is also highlighted in several industry sectors in
our study. Measurements of respirable crystalline silica in the UK
construction industry have found levels that greatly exceed the
current maximum exposure limit of 0.3mgm
 3, particularly for
work in confined spaces and without water suppression of dust or
effective extraction (Chisholm, 1999).
Diesel engines have a wide range of industrial applications
including on-road equipment (most heavy and medium duty
trucks and buses use diesel engines), and off-road applications in
the mining, rail, construction, distribution and farming industries
and in the military, including the use of diesel-powered heavy
equipment, locomotives, forklift trucks, ships, tractors and
generators. In a recent review, the highest levels of elemental
carbon (EC) were reported for enclosed underground work sites in
mining and construction (EC 27–658mgm
 3) (Pronk et al, 2009).
Intermediate levels were reported for above-ground semi-enclosed
areas involving work as a workshop mechanic, dock worker and
fire station workers (ECo50mgm
 3), with the lowest levels
(ECo25mgm
 3) reported for enclosed areas separated from the
source, such as drivers, train crew, parking attendants, vehicle
testers and utility service workers.
Cancer in non-smokers due to workplace exposure to ETS may
be expected to largely disappear in Britain in future due to the ban
now in force; our results imply the importance of this exposure
in countries where no ban is yet enforced. Carcinogens such as
naturally occurring radon could also easily be eliminated from
workplaces. Our study has extended evaluation of more ‘tradi-
tional’ industrial hazards such as asbestos to estimation of the
effect of newer and less traditional problems. In 2007 IARC
classified shift work, in particular night work, as being group 2A
for breast cancer (Straif et al, 2007). The estimate of nearly 2000
breast cancer registrations due to shift work in our study is 54% of
all female occupationally related cancer registrations (1969/3616).
The epidemiological evidence evaluated by IARC comes from
population-based case–control studies and studies of nurses,
marine telephone operators and female flight attendants, although
in the latter the effects of concomitant exposure to shift work and
ionising radiation is difficult to disentangle. Large studies in other
industry groups with collection of good shift pattern data are
needed. Denmark recently became the first country to designate
breast cancer as an occupational disease eligible for receiving
compensation (Commentary, 2009). The ramifications of this
decision and of our results could be significant, given the
large numbers of women working night shifts in Britain and
worldwide.
Exposure to SR and mineral oils at work was associated with a
large number of registrations of NMSC (21% of all attributable
registrations). Mortality from NMSC is low but there may
be appreciable morbidity from disfigurement as the lesions tend
to be on the head and neck; their high prevalence represents a
considerable health service burden (Houseman et al, 2003; Boyle
et al, 2004; Trakatelli et al, 2007). As NMSC is thought to be
substantially underregistered, our occupational figures are also
likely to be underestimated.
The ANs and AFs presented in this paper provide a basis on
which to inform prioritisation of future effort both for health and
safety strategic planning and for research to fill information gaps.
Reduction and removal of these carcinogens might be expected to
increase average life expectancy. Other measures such as years
of life lost and disability-adjusted life years will be estimated as
part of our on-going study.
In summary, this project is the first to quantify in detail the
burden of cancer due to occupation specifically for Britain.
It highlights the impact of such exposures on cancer morbidity
and mortality, together with the occupational circumstances and
industrial areas where exposures to these agents occurred in the
past; this can be compared with the impact of other causes of
cancer. Risk reduction strategies should focus on those workplaces
where such exposures are still occurring.
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Statistical Appendix
FORMULAE USED IN THE ESTIMATION OF AF
1. Levin’s equation
AF ¼ PrðEÞðRR   1Þ=f1 þ PrðEÞðRR   1Þg ð1Þ
where RR¼relative risk, Pr(E)¼proportion of the population
exposed.
A common denominator is used across exposure levels and
industries for each exposure.
2. Miettinen’s equation
AF ¼ PrðEjDÞðRR   1Þ=RR ð2Þ
where Pr(E|D)¼proportion of cases exposed (E¼exposed,
D¼case).
3. Turnover equation to estimate numbers ever employed during
the REP
NeðREPÞ¼
X i¼b
i¼a
lðadj15Þin0=ðR   15Þ
þ
X k¼ðageðuÞ ageð1ÞÞ
k¼0
X j¼dþk
j¼cþk
f1ðadj15Þjn0TO=ðageðuÞ ageð1Þþ1Þg
ð3Þ
where Ne(REP)¼numbers ever employed in the REP; n0¼numbers
employed in the exposed job/industry at a mid-point in the REP;
TO¼staff turnover per year; R¼retirement age (65 for men, 60
for women); l(adj15)i¼the proportion of survivors to age i of those
alive at age 15 (from GB life tables); a to b¼age range achieved by
the original cohort members by the target year (2004) (e.g., 65–100
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turnover recruited cohort members by the target year (25–64 for
the solid tumour REP); age(u) and age(l)¼upper and lower
recruitment age limits (24 and 15). The equation can be
represented as a single factor behaving as a multiplier for n0,
calculated by setting n0 to 1 in the above equation, so that the
factor varies only with TO, see Table A1.
4. Equation to estimate the proportion of the population exposed
PrðEÞ¼NeðREPÞ=NpðREPÞ ð4Þ
where Np(REP)¼numbers ever of working age during the REP from
population estimates for the relevant age cohorts in the target year.
5. Equation for combining AFs where exposed populations overlap
but are independent and risk estimates are assumed to be
multiplicative:
AFoverall¼ 1 Pkð1   AFkÞð 5Þ
for the k exposures in the set.
Table A1 Employment level adjustment and turnover factors used in
the calculation of AF
Main industry sector
Adjustment
factor for
change in
employment
levels
a
Turnover
per
year (%)
Men
A–B Agriculture, hunting and forestry; fishing 1 7
C–E Mining and quarrying, electricity, gas
and water; manufacturing industry
1.4 9
F Construction 1 12
G–Q Service industries 0.9 11
Total 1 10
Women
A–B Agriculture, hunting and forestry; fishing 0.75 10
C–E Mining and quarrying, electricity, gas
and water; manufacturing industry
1.5 14
F Construction 0.67 15
G–Q Service industries 0.8 15
Total 0.9 14
aApplied to CAREX data for the solid tumour REP only. Exposed numbers are
obtained for a mid-point year in the REP where national employment data sources
have been used (the LFS or CoE).
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